Coronary artery bypass graft versus percutaneous coronary intervention in acute heart failure
Abstract
Objective - myocardial ischaemia is a leading cause of acute heart failure (AHF). However, optimal revascularisation strategies in AHF are unclear. We aimed to compare two revascularisation strategies, coronary artery bypass graft (CABG) and percutaneous coronary
Association of β-blocker therapy at discharge with clinical outcomes after acute coronary syndrome in patients without heart failure
Abstract
Aim - to evaluate the clinical impact of β -blocker in patients with adequate left ventricular ejection function (LVEF) who underwent percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Methods . A total of 10,724 consecutive patients who
Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction results from the DAPA-HF trial
Abstract
Background . Goals of management in patients with heart failure and reduced ejection fraction include reducing death and hospitalizations, and improving health status (symptoms, physical function, and quality of life). In the DAPA-HF trial (Dapagliflozin and Prevention of
Modern diagnostic methods in nuclear cardiology
Abstract
Cardiovascular diseases present main cause of deaths in the developed and developing countries. That is why early diagnostics problems in cardiology are the subject for multiple scientific researches and discussions. Last years nuclear medicine methods play an essential role
Heterogeneity of atherosclerosis
Abstract
Cardiovascular events associated with atherosclerosis can develop by achieving treatment goals following current clinical guidelines and failure to achieve the set goals, including risk factors such as dyslipidemia, high blood pressure, hyperglycemia, systemic inflammation,